Related Experiment Video
Updated: Jun 12, 2026
10:39
3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
Migraine in the pediatric population--evolving concepts.
Marcelo E Bigal1, Marco A Arruda
1Office of the Chief Medical Officer-Merck inc. Upper Gwynedd, PA, USA.
Headache
|June 25, 2010
Summary
Pediatric migraine is common in children and adolescents. Current diagnostic criteria may be too strict for young children, and early life exposures could influence migraine progression.
Area of Science:
- Neurology
- Pediatrics
- Epidemiology
Background:
- Headache research is crucial across all age groups, particularly in pediatrics.
- Understanding early childhood headaches is less advanced than in adolescents.
- Epidemiological studies are vital for understanding headache prevalence and determinants.
Purpose of the Study:
- To provide a theoretical framework for understanding pediatric headaches.
- To summarize findings from an epidemiological study on pre-adolescent headaches.
- To explore factors influencing migraine progression in children.
Main Methods:
- Review of current understanding of pediatric headaches.
- Analysis of data from a large, ongoing epidemiological study in pre-adolescent children.
- Examination of potential risk factors including family history and prenatal exposures.
Main Results:
- Migraine is frequent in both pre-adolescents and adolescents.
- Existing diagnostic criteria for migraine and chronic migraine may be inappropriate for young children.
- Migraine episodes in young children often last less than one hour.
- A subset of children is at risk for migraine progression, influenced by genetics and early life exposures.
- Family history of headaches and prenatal exposures are relevant risk factors.
- Migraine is associated with behavioral hyperactivity but not attention-deficit/hyperactivity disorder.
Conclusions:
- Migraine is a significant issue in pre-adolescent children, requiring tailored diagnostic approaches.
- Early life factors, including prenatal exposures and family history, play a role in migraine development and progression.
- Further research is needed to refine diagnostic criteria and understand the pathophysiology of pediatric migraine.
Related Concept Videos
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:29Increased Intracranial Pressure ll: Pathophysiology
Increased intracranial pressure (ICP) refers to a potentially life-threatening rise in pressure inside the skull. This usually happens when there is a major change in the volume of brain tissue, blood, or cerebrospinal fluid (CSF) — the three components inside the skull. According to the Monro-Kellie doctrine, if the volume of one component increases, the volumes of the other components must decrease to maintain normal pressure. If this does not happen, ICP rises.The process often begins with...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
01:14Increased Intracranial Pressure l: Introduction
Intracranial hypertension is a sustained elevation of intracranial pressure (ICP) above 22 mm Hg. In supine adults, normal ICP is ~7–15 mm Hg.The rigid, nonexpandable cranium contains three components—brain tissue, blood, and cerebrospinal fluid (CSF)—that total ~1,700 mL in a typical adult: 1,400 mL brain (~80%), 150 mL blood (~10%), and 150 mL CSF (~10%). According to the Monro–Kellie doctrine, total intracranial volume is effectively fixed. When one component expands, CSF and venous blood...